LI Zhen
No ORCID on file
· 49 papers in corpus
· active 2001-2020
Study types
- article 1
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- NEILSON Lorna 36
- NEILSON LORNA I 12
- Gu CL 1
- Li LA 1
- Li-An Li 1
- Li Z 1
- Ming-Xia Ye 1
- Meng YG 1
- Ni-Na Zhang 1
- Qian Zhang 1
article
2020
Endometriosis, as a prevalent gynecological disease, is characterized by the presence of endometrial-like tissue outside the uterus, causing infertility and considerable pain and affecting the quality of life of women. The pathogenic mechan…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2004
There is disclosed a method of measuring an amount of antileukoprotease in an endometrial tissue sample which has been obtained from a human subject, which comprises measuring an amount of antileukoprotease activity or antileukoprotease mRN…
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.
2003
This invention provides methods for diagnosing and treating endometriosis, and promoting implantation of an embryo. The methods involve determining or modulating antileukoprotease activity in a subject.